Estimating the Neutral Rate of Nucleotide Substitution Using Introns
Overview
Authors
Affiliations
Evolutionary biologists frequently rely on estimates of the neutral rate of evolution when characterizing the selective pressure on protein-coding genes. We introduce a new method to estimate this value based on intron nucleotide substitutions. The new method uses a metascript model that considers alternative splicing forms and an algorithm to pair orthologous introns, which we call Introndeuce. We compare the intron method with a widely used method that uses observed substitutions in synonymous coding nucleotides, by using both methods to estimate the neutral rate for human-dog and mouse-rat comparisons. The estimates of the 2 methods correlate strongly (r(S) = 0.75), but cannot be considered directly equivalent. We also investigate the effect of alignment error and G + C content on the variance in the intron method: in both cases there is an effect, and it is species-pair specific. Although the intron method may be more useful for shorter evolutionary distances, it is less useful at longer distances due to the poor alignment of less-conserved positions.
Introns: the "dark matter" of the eukaryotic genome.
Girardini K, Olthof A, Kanadia R Front Genet. 2023; 14:1150212.
PMID: 37260773 PMC: 10228655. DOI: 10.3389/fgene.2023.1150212.
Animal Models for Postoperative Implant-Related Spinal Infection.
Wang Y, Che M, Zheng Z, Liu J, Ji X, Sun Y Orthop Surg. 2022; 14(6):1049-1058.
PMID: 35466555 PMC: 9163983. DOI: 10.1111/os.13238.
KaKs_Calculator 3.0: Calculating Selective Pressure on Coding and Non-coding Sequences.
Zhang Z Genomics Proteomics Bioinformatics. 2022; 20(3):536-540.
PMID: 34990803 PMC: 9801026. DOI: 10.1016/j.gpb.2021.12.002.
Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer.
Gray M, Meehan J, Martinez-Perez C, Kay C, Turnbull A, Morrison L Front Oncol. 2020; 10:617.
PMID: 32411603 PMC: 7198768. DOI: 10.3389/fonc.2020.00617.
Companion Animals as Models for Inhibition of STAT3 and STAT5.
Kieslinger M, Swoboda A, Kramer N, Pratscher B, Wolfesberger B, Burgener I Cancers (Basel). 2019; 11(12).
PMID: 31861073 PMC: 6966487. DOI: 10.3390/cancers11122035.